:max_bytes(150000):strip_icc()/GettyImages-2231040290-274cf889db25411f9b4e26d68f432e77.jpg)
Major U.S. equities broadly declined Friday, with the S&P 500 down 0.3%, as a soft August jobs report fueled economic growth concerns but simultaneously solidified expectations for an imminent Federal Reserve rate cut. This led to highly divergent stock performance: Lululemon plummeted 18.6% on weak same-store sales and a trimmed outlook, while Broadcom surged 9.4% after exceeding estimates due to robust AI chip demand, including a 63% year-over-year increase in AI revenue. Other notable movers included Kenvue's 9.4% drop on Tylenol-autism report concerns, AMD's 6.6% decline on slowing AI demand worries, and Pool Corp.'s 5.5% gain on rate cut optimism.
The market exhibited significant divergence on Friday, as macroeconomic concerns clashed with specific corporate and sector-level drivers. A weaker-than-expected August jobs report, which included the first monthly job loss since 2020 after revisions, pushed the S&P 500 down 0.3% and the Dow 0.5%, fueling fears of an economic slowdown. However, this same data solidified expectations for a Federal Reserve interest rate cut, causing the 10-year Treasury yield to fall and creating a tailwind for rate-sensitive stocks like Pool Corp (POOL), which rallied 5.5%. This split narrative was most evident in individual stock performance. The artificial intelligence theme showed fissures, with Broadcom (AVGO) surging 9.4% on a strong earnings beat, a 63% YoY increase in AI revenue, and a reported $10 billion order from a new major client. Conversely, Advanced Micro Devices (AMD) fell 6.6% following a downgrade from Seaport Research citing slowing demand for its AI accelerators. In consumer discretionary, Lululemon (LULU) was the S&P 500's worst performer, plummeting 18.6% after reporting soft same-store sales and cutting its full-year guidance due to tariff impacts and sluggish U.S. demand. Meanwhile, Kenvue (KVUE) faced severe event-driven risk, dropping 9.4% on reports of a potential government study linking its Tylenol product to autism.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Overall Sentiment
mixed
Sentiment Score
0.00
Ticker Sentiment